Explore another way you may receive treatment.

Potential OPDIVO® (nivolumab) user taking a selfie with his son.
Potential OPDIVO® (nivolumab) user taking a selfie with his son.

Giving you a choice and
a chance
against cancer

OPDIVO is a proven immunotherapy to help your body fight against cancer. Alone or in combination with other therapies, OPDIVO is approved by the FDA to be a first treatment option for many types of cancer. Talk to your healthcare provider to find out if OPDIVO or an OPDIVO‑based combination is right for you.

Actor portrayals.
OPDIVO and OPDIVO Qvantig are not approved
for people younger than 18 years of age.

Hands exploring how OPDIVO® (nivolumab) works and learning how this treatment may help fight cancer.

Explore another way you may receive treatment

You and your healthcare provider may have a choice between under-the-skin injections (subcutaneous injection) with OPDIVO Qvantig and intravenous (lV) infusions with OPDIVO

Hands perusing OPDIVO® (nivolumab) patient resources.

Helpful patient resources

Explore resources to help you along your treatment journey

Frequently asked questions about treatment with OPDIVO® (nivolumab).

Have questions about treatment?

We have answers about getting treatment, monitoring, and more

Hands exploring cost information and financial help for OPDIVO® (nivolumab).

Cost information and financial help

Find information about cost and access to OPDIVO

OPDIVO and OPDIVO Qvantig will not work for everyone. Individual results may vary.